6 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of potent and bioavailable GSK-3beta inhibitors.

Roche Palo Alto
A quantitative analysis of kinase inhibitor selectivity.

Ambit Biosciences
Comprehensive analysis of kinase inhibitor selectivity.

Ambit Biosciences
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).

Ambit Biosciences
CDK9 inhibitors in cancer research.

Nankai University